Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
01/2007
01/04/2007US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents
01/04/2007US20070004718 Ion channel modulating compounds and uses thereof
01/04/2007CA2667445A1 Hiv-1 protease inhibitors
01/04/2007CA2613354A1 Non-nucleoside anti-hepacivirus agents and uses thereof
01/04/2007CA2612290A1 Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate
01/03/2007EP1739085A1 Cosmetic composition containing a double para-phenylenediamines joined by an aromatic group and use in dyeing
01/03/2007EP1737868A1 Stereoselective method for the production of clopidogrel
01/03/2007EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
01/03/2007EP1737813A1 Androgen modulators
01/03/2007EP1737811A1 Cetp inhibitors
01/03/2007EP1633699B1 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
01/03/2007CN1890233A Sulfoxyalkylthiophene compound and process for producing the same
01/03/2007CN1890216A Carboxamide derivatives
01/03/2007CN1293080C Process for the preparation of clopidogrel
01/03/2007CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
01/03/2007CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides
01/03/2007CN1293034C New gamma selective retinoids
01/02/2007US7157594 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea
01/02/2007US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
01/02/2007US7157491 Hydroxy-phenyl)-aryl-carbaldehyde oxime derivatives; estrogen receptor modulators, treating inflammatory bowel diseases, Crohn's disease and colitis
01/02/2007US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders
01/02/2007US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007CA2274464C Ketobenzamides as calpain inhibitors
01/02/2007CA2218892C Diaromatic propynyl or dienyl compounds
12/2006
12/28/2006WO2006137210A1 Benzothiophene derivative and organic electroluminescence device making use of the same
12/28/2006WO2006137019A1 Novel thiophene derivatives
12/28/2006WO2006136823A1 Heterocyclic containing amines as kinase b inhibitors
12/28/2006WO2006135978A1 Antiviral compounds and methods
12/28/2006WO2006089954A3 Compounds for stabilizing factor vii polypeptide formulations
12/28/2006WO2006058648A3 Biaryloxymethylarene carboxylic acids
12/28/2006WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors
12/28/2006US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile
12/28/2006US20060293380 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2006US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
12/28/2006US20060293300 New substituted thiophene carboxamides, process for their preparation and their use as medicaments
12/28/2006DE102005030314A1 New triarylamine-derivates useful as hole transportation substance or luminescent substance in an organic electroluminescent device; and as hole transportation substance in an electrophotographic arrangement
12/28/2006CA2612661A1 Novel thiophene derivatives
12/28/2006CA2612403A1 Antiviral compounds and methods
12/27/2006EP1736465A1 Aniline derivatives
12/27/2006EP1735319A1 Inhibitors of histone deacetylase
12/27/2006EP1735300A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/27/2006EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/27/2006EP1735275A2 Aryl sulfones and uses related thereto
12/27/2006EP1735270A1 Diamino alcohols and their use as renin inhibitors
12/27/2006EP1735268A1 Opioid receptor antagonists
12/27/2006EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006EP1404687B1 Fluorous triphase and other multiphase systems
12/27/2006EP1390344B1 Benzamidoacetonitrile derivatives and their use as antiparasitics
12/27/2006EP1187826B1 Heterocyclic derivatives useful as anticancer agents
12/27/2006EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006CN1886396A Process for producing 2-acylthiophene compound
12/27/2006CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups
12/27/2006CN1886365A Novel salicylic anilides
12/27/2006CN1884279A 3-oxy -2,3-í�Híübenzothiophene 1,1-dioxygen synthesis method
12/27/2006CN1884278A Glucagon-like peptide-1 receptor regulator, its preparation method and uses
12/27/2006CN1291969C Oligofluorenylene compounds
12/26/2006US7154007 Compounds with perfluoroalkanoacetophenone groups that form complexes with rare earth elements that can be used in immunoassays or nucleic acid assays for labeling a protein, peptide, amino acid, nucleic acid, or nucleotide
12/26/2006US7153980 Useful for organo-electronic devices such as electrophotographic photoreceptors (photosensitive elements), organic electroluminescent elements and organic transistors, charge-transporting properties and luminous properties
12/26/2006US7153869 Substituted amino acids as erythropoietin mimetics
12/26/2006US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative
12/26/2006US7153809 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
12/21/2006WO2006135694A2 Uii-modulating compounds and their use
12/21/2006US20060287536 Phenyl-thiophene type vitamin d receptor modulators
12/21/2006US20060287402 Cathepsin inhibitors
12/21/2006US20060287396 4-aryl quinols and analogs thereof as therapeutic agents
12/21/2006US20060287393 Novel compounds, their preparation and use
12/21/2006US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/21/2006US20060287386 Benzo[b]furane and benzo[b]thiophene derivatives
12/21/2006US20060287385 Contacting cell with hedgehog antagonist; moderator of cell proliferative, cell differentiation
12/21/2006US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006US20060286065 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro
12/20/2006EP1734041A2 Platelet ADP receptor inhibitors
12/20/2006EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders
12/20/2006EP1732922A1 Methods for minimizing thioamide impurities
12/20/2006EP1732920A2 Thiophene derivatives as chk 1 inhibitors
12/20/2006EP1732895A2 Insecticidal n-substituted sulfoximines
12/20/2006EP1732884A1 Sulphonamide derivatives
12/20/2006EP1732882A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
12/20/2006EP1551822B1 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
12/20/2006EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006CN1882563A Antidiabetic compounds comprising benzofuran and benzothiophene derivatives
12/20/2006CN1882562A Benzofurans and benzothiophenes
12/20/2006CN1882561A Substituted naphthyl benzothiophene acids
12/20/2006CN1882533A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2006CN1882530A Amidines and derivatives thereof and pharmaceutical compositions containing them
12/20/2006CN1882529A Inhibitors of histone deacetylase
12/20/2006CN1882528A Organic compounds
12/20/2006CN1882527A Biphenyloxy-acids
12/20/2006CN1290806C Methods, systems and catalysts for use in aromatic alkylation reactions
12/19/2006US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/14/2006WO2006133339A2 Monoamine re-uptake inhibitors and methods relating thereto
12/14/2006WO2006132811A2 Ampa receptor potentiators
12/14/2006WO2006132442A1 Vitamin d-like compound
12/14/2006WO2006131398A2 Inhibitors of soluble adenylate cyclase
12/14/2006WO2006115835A3 Benzothiophene hydroxamic acid derivatives
12/14/2006WO2006086488A3 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
12/14/2006US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals